We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-14.68%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.34B
AUM Growth
-$500M
Cap. Flow
+$164M
Cap. Flow %
4.9%
Top 10 Hldgs %
9.82%
Holding
1,404
New
145
Increased
727
Reduced
365
Closed
141

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14M
2
PG icon
Procter & Gamble
PG
+$11.3M
3
KR icon
Kroger
KR
+$10.6M
4
NOC icon
Northrop Grumman
NOC
+$8.11M
5
BIIB icon
Biogen
BIIB
+$8.03M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Energy 13.98%
3 Healthcare 13.42%
4 Industrials 10.8%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHI icon
1101
PLDT
PHI
$4.25B
$219K 0.01%
+7,158
New +$254K
AMRC icon
1102
Ameresco
AMRC
$1.34B
$218K 0.01%
4,799
+96
+2% +$5.34K
IDT icon
1103
IDT Corp
IDT
$1.61B
$218K 0.01%
8,685
+873
+11% +$24.1K
EL icon
1104
Estee Lauder
EL
$31.5B
$217K 0.01%
826
-651
-44% -$165K
RDWR icon
1105
Radware
RDWR
$1.2B
$217K 0.01%
10,041
+1,026
+11% +$26.9K
PK icon
1106
Park Hotels & Resorts
PK
$2.92B
$215K 0.01%
15,923
-279
-2% -$4.93K
SSL icon
1107
Sasol
SSL
$7.38B
$215K 0.01%
+9,420
New +$232K
PXD
1108
DELISTED
Pioneer Natural Resource Co.
PXD
$215K 0.01%
957
-319
-25% -$80.9K
ACWX icon
1109
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
$214K 0.01%
+4,749
New +$230K
FLNC icon
1110
Fluence Energy
FLNC
$2.34B
$214K 0.01%
22,565
+357
+2% +$3.48K
UTHR icon
1111
United Therapeutics
UTHR
$22.7B
$214K 0.01%
+935
New +$190K
DXCM icon
1112
DexCom
DXCM
$33.1B
$213K 0.01%
2,831
+15
+0.5% +$1.37K
BEAM icon
1113
Beam Therapeutics
BEAM
$2.82B
$212K 0.01%
5,548
+723
+15% +$28.7K
U icon
1114
Unity
U
$19B
$212K 0.01%
+5,905
New +$335K
VOYA icon
1115
Voya Financial
VOYA
$9.09B
$212K 0.01%
3,580
+165
+5% +$10.6K
AU icon
1116
AngloGold Ashanti
AU
$49.2B
$211K 0.01%
14,487
+4,941
+52% +$93.8K
SLAI
1117
DELISTED
SOLAI Ltd ADS
SLAI
$210K 0.01%
4,829
+12
+0.2% +$1.5K
FCEL icon
1118
FuelCell Energy
FCEL
$1.59B
$210K 0.01%
1,869
-74
-4% -$9.33K
TCOM icon
1119
Trip.com Group
TCOM
$29.7B
$210K 0.01%
+7,598
New +$170K
FOX icon
1120
Fox Class B
FOX
$23.6B
$209K 0.01%
7,131
+411
+6% +$13.4K
INCY icon
1121
Incyte
INCY
$24.6B
$209K 0.01%
2,753
-5,134
-65% -$390K
MSTR icon
1122
Strategy Inc
MSTR
$37.4B
$209K 0.01%
12,920
+5,730
+80% +$166K
NLY icon
1123
Annaly Capital Management
NLY
$17.3B
$209K 0.01%
8,869
-8,038
-48% -$208K
CF icon
1124
CF Industries
CF
$18.4B
$208K 0.01%
+2,409
New +$234K
NVS icon
1125
Novartis
NVS
$298B
$208K 0.01%
+2,448
New +$215K

Similar funds

Vident Investment Advisory's Q2 2022 Portfolio in Review

As of Q2 2022, Vident Investment Advisory held 1,404 positions worth $3.34B, down 13% from $3.84B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Vident Investment Advisory deployed $164M of net new capital in Q2 2022, opening 145 new positions and adding to 727 existing holdings. Its largest new stake was Samsara: 1,361,007 shares worth $15.2M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Walmart Inc, an estimated $14M trimmed.

  • Vident Investment Advisory's largest Q2 2022 buy was Samsara: 1,361,007 shares worth $15.2M.
  • Vident Investment Advisory added most to Meta Platforms (Facebook) in Q2 2022, an estimated $13.4M increase.
  • Vident Investment Advisory's biggest Q2 2022 reduction was Walmart Inc, cutting an estimated $14M.
  • Vident Investment Advisory fully exited Cerner Corp in Q2 2022, selling an estimated $7.01M.
  • Vident Investment Advisory's ten largest holdings make up 9.8% of its $3.34B portfolio in Q2 2022.
  • Vident Investment Advisory opened 145 new positions and closed 141 in Q2 2022.
  • Vident Investment Advisory's portfolio value fell 13% quarter-over-quarter to $3.34B.

Based on Vident Investment Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.